Home / Anti-infectives / Atazanavir and Cobicistat
ATC J05AR15 · Antivirals for Treatment of Hiv Infections, Combinations · updated 2 Nov 2026
Atazanavir and Cobicistat shortage
As of 2 Nov 2026, Atazanavir and Cobicistat has a reported shortage in 1 of the 16 countries we track (United States), covering 1 product from 1 company.
Is there an Atazanavir and Cobicistat shortage?
Yes. As of 2 Nov 2026, Atazanavir and Cobicistat is reported short in 1 of the 16 countries we track: United States. No company has given a return date.
Timeline
Solid bars run from the reported start to today; faded bars show the time left until the expected return. An arrow means no return date was given.
Which companies are short
products short, all countriesListed: Bristol Myers Squibb BMY · NYSE
Compared with similar medicines
ATC group J05AR · Antivirals for Treatment of Hiv Infections, CombinationsAffected products
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| US | Evotaz, Tablet, 300 mg; 150 mg (NDC 0003-3641-11) discontinuation | Bristol Myers Squibb Co. | 3 Nov 2025 | not given | Not stated |
"Expected back" is the date the company gave the authority, when it gave one. Ask a pharmacist about alternatives.
Questions
Is there an Atazanavir and Cobicistat shortage?
Yes. As of 2 Nov 2026, Atazanavir and Cobicistat is reported short in 1 of the 16 countries we track: United States. No company has given a return date.
When will Atazanavir and Cobicistat be back in stock?
No return date has been given; United States: no date given. These are company estimates reported to each authority.
Why is Atazanavir and Cobicistat in short supply?
The most common reason reported is: not stated. Reasons by product are listed in the table below.
Which companies have Atazanavir and Cobicistat shortages?
Bristol Myers Squibb.